Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial

Table 2 Timetable and measures to be made

	Screening	Month 0 (baseline)	Week 4	Month 6	Month 12	Month 18	Month 24
X-ray	√
Biochemical testing	√		√	√	√		√
Questionnaires	√	√		√	√		√
Knee VAS	√	√		√	√		√
Knee WOMAC		√		√	√		√
IPAQ		√					√
SF-36		√					√
Concomitant medications	√	√		√	√		√
Smoking		√					√
History of joint disease	√	√					√
Co-morbidities	√	√					√
Education and occupation		√
Physical examination		√					√
Height and weight		√					√
Lower limb muscle strength		√			√		√
Knee MRI		√					√
Compliance and adverse events				√	√	√	√
Medication dispensing		√		√	√	√

ISSN: 1745-6215